Lenskart has emerged from challenger to market leader, with Nomura initiating coverage with a ‘Buy’ rating and Rs 888 target, implying arou...

AMFI has re-elected Sundeep Sikka as Chairman and Vishal Kapoor as Vice Chairman for another term. Sikka, MD and CEO of Nippon Life India A...

JioBlackRock Mutual Fund will launch the JioBlackRock Balanced Advantage Fund in September, with the NFO open for subscription from Septemb...

Lenskart Solutions experienced institutional transactions totaling Rs 1,857 crore on August 28. Numerous domestic and global investors purc...

Around 49 equity mutual funds delivered over 15% CAGR in both the last three and five years, according to an ETMutualFunds analysis. HSBC M...

Jefferies initiated coverage on SBI Funds Management with a Buy rating and a Rs 710 price target, implying 26% upside. The brokerage expect...

As per Sebi mandate, medium duration funds must invest in debt and money market instruments with Macaulay duration of three to four years.

Sovereign gold bonds: Non-Resident Indians cannot invest in Sovereign Gold Bonds currently. However, existing bondholders can continue hold...

Around 12 equity mutual funds turned a Rs 10,000 monthly SIP into more than Rs 11 crore since their respective inceptions, an ETMutualFunds...

Piramal Finance’s first QIP since listing attracted bids worth around Rs 21,000 crore, nearly 10 times the Rs 2,100 crore on offer, amid st...

According to the Sebi mandate, short duration funds can invest in debt instruments which have maturity between one and three years. That me...

R Sivakumar, CIO, Axis Mutual Fund, believes the starting point should be a diversified asset-allocation framework rather than market views...

Netweb Technologies shares fell nearly 4% after the company completed its Rs 1,200 crore Qualified Institutions Placement (QIP), its first ...

Gilt funds are not recommended to regular debt investors because they are risky and volatile. Gilt funds suffer the most when the rates go ...

Y Combinator-linked entities sold 4.85 crore Meesho shares worth Rs 970 crore through block deals at Rs 200.01 apiece. Institutional buyers...

Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...

If you are investing for three years and aware of the risks associated with these schemes, you can consider investing in Banking & PSU sche...